Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CERUS CORPCERS · Entity 5431 | Chief Medical Officer | March 12, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CERUS CORP
Report date March 12, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 777,361 |
Reported balance
After 2026-03-12 transaction · row 1
1 source rowRow 1 · 2026-03-12 · Sale · Disposed 101,740 · Balance 777,361 F1: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.73 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
F2: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.73 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2021 Filed Nov 5, 2021 23:41 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 31,667 | $7.35 | $232,752.45 |
DisclosureSEC source: 0001209191-21-063270 · doc4.xml · nonDerivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,035 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:41 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 31,667 | $4.32 | $136,801.44 |
DisclosureSEC source: 0001209191-21-063270 · doc4.xml · nonDerivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:41 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 33,333 | $7.35 | $244,997.55 |
DisclosureSEC source: 0001209191-21-063270 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,035 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:41 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 33,333 | $4.33 | $144,331.89 |
DisclosureSEC source: 0001209191-21-063270 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:41 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 100,000 | $7.90 | $790,000.00 |
DisclosureSEC source: 0001209191-21-063270 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,035 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 23:41 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 100,000 | $4.72 | $472,000.00 |
DisclosureSEC source: 0001209191-21-063270 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 20,000 | $6.34 | $126,780.00 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 7 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,035 F4 · price: This transaction was executed pursuant to a 10b5-1 plan.The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.29 to $6.42 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 7,989 | $6.38 | $50,951.45 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,035 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,254 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 5,556 | $6.38 | $35,434.50 |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,040 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · derivative · entry 10 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,230 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F8 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F8 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · derivative · entry 9 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · derivative · entry 8 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:32 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021133 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:59 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-017439 · doc4.xml · derivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:59 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $6.52 | Not disclosed |
DisclosureSEC source: 0001209191-21-017439 · doc4.xml · derivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| August 24, 2020 Filed Aug 27, 2020 00:20 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $4.72 | Not disclosed |
DisclosureSEC source: 0001209191-20-048463 · doc4.xml · derivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Not applicable. F3 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Read SEC document |
| August 24, 2020 Filed Aug 27, 2020 00:20 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 100,000 | $7.90 | $790,000.00 |
DisclosureSEC source: 0001209191-20-048463 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,763 F2 · shares: This transaction was executed pursuant to a 10b5-1 plan and does not represent a discretionary sale by the reporting person. Read SEC document |
| August 24, 2020 Filed Aug 27, 2020 00:20 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 100,000 | $4.72 | $472,000.00 |
DisclosureSEC source: 0001209191-20-048463 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 31,666 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · derivative · entry 9 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,750 Underlying: Common Stock · 31,666 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 22,917 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · derivative · entry 8 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 22,917 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $4.72 | Not disclosed |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · derivative · entry 7 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 31,666 | $7.20 | $228,004.70 |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,763 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 31,666 | $4.32 | $136,797.12 |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 22,917 | $7.20 | $165,009.28 |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,763 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 22,917 | $4.33 | $99,230.61 |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 100,000 | $7.20 | $720,030.00 |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,763 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| July 07, 2020 Filed Jul 10, 2020 00:45 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 100,000 | $4.72 | $472,000.00 |
DisclosureSEC source: 0001209191-20-042067 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 17,497 | $3.59 | $62,896.47 |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · nonDerivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,763 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · nonDerivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 6,051 | $3.59 | $21,751.53 |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,260 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 3,022 | $3.59 | $10,863.18 |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,478 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · derivative · entry 9 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · derivative · entry 8 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:09 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021044 · doc4.xml · derivative · entry 7 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:01 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021101 · doc4.xml · derivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 69,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:01 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 138,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021101 · doc4.xml · derivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Underlying: Common Stock · 138,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 21:12 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 16,444 | $5.01 | $82,323.60 |
DisclosureSEC source: 0001209191-19-045379 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.035 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:21 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 135,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-035787 · doc4.xml · derivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 00:28 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 5,979 | $5.90 | $35,273.71 |
DisclosureSEC source: 0001209191-19-019299 · doc4.xml · nonDerivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,444 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 00:28 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 2,832 | $5.90 | $16,711.07 |
DisclosureSEC source: 0001209191-19-019299 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,589 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:28 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019299 · doc4.xml · derivative · entry 9 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,666 Underlying: Common Stock · 15,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:28 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019299 · doc4.xml · derivative · entry 8 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:28 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019299 · doc4.xml · nonDerivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:28 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019299 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:28 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 1,079 | $6.48 | $6,991.92 |
DisclosureSEC source: 0001209191-19-019299 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,921 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.